T. Rowe Price Associates, Inc. 13D and 13G filings for CARGO Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-14 10:45 am Sale |
2025-03-31 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX |
T. Rowe Price Associates, Inc. | 597,682 1.300% |
-2,096,624 (-77.82%) |
Filing |
| 2024-11-14 1:22 pm Purchase |
2024-09-30 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX |
T. Rowe Price Associates, Inc. | 2,694,306 5.900% |
455,799 (+20.36%) |
Filing |
| 2024-02-14 10:03 am Purchase |
2023-12-31 | 13G | CARGO Therapeutics, Inc. Common Stock CRGX |
T. Rowe Price Associates, Inc. | 2,238,507 5.400% |
2,238,507 (New Position) |
Filing |